Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
38 hedge funds and large institutions have $74.3M invested in Applied Genetic Technologies Corporation in 2014 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
7,335% more capital invested
Capital invested by funds: $999K → $74.3M (+$73.3M)
3,700% more funds holding
Funds holding: 1 → 38 (+37)
3,700% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$12.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.6M |
| 3 |
VAM
Visium Asset Management
New York
|
+$6.92M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.85M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$3.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$999K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
26
Panagora Asset Management
Boston,
Massachusetts
| $127K | +$96.5K | +5,479 | New |
|
|
AIG
27
American International Group
New York
| $73.3K | +$55.9K | +3,172 | New |
|
|
BA
28
BlackRock Advisors
Wilmington,
Delaware
| $48K | +$36.4K | +2,067 | New |
|
29
AllianceBernstein
Nashville,
Tennessee
| $37K | +$28.2K | +1,600 | New |
|
30
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $35K | +$26.4K | +1,498 | New |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $16K | +$12.2K | +690 | New |
|
|
U
32
UBS
Zurich,
Switzerland
| $12K | +$9K | +511 | New |
|
|
VFA
33
Virtus Fund Advisers
Hartford,
Connecticut
| $10K | +$7.28K | +413 | New |
|
34
Morgan Stanley
New York
| $8K | +$5.92K | +336 | New |
|
35
Wells Fargo
San Francisco,
California
| $8K | +$6.08K | +345 | New |
|
|
GSC
36
Ground Swell Capital
Folly Beach,
South Carolina
| $5K | +$3.47K | +197 | New |
|
37
Barclays
London,
United Kingdom
| $2K | +$1.87K | +106 | New |
|
38
Citigroup
New York
| $1K | +$722 | +41 | New |
|
|
39
Alyeska Investment Group
Chicago,
Illinois
| – | -$999K | -66,579 | Closed |
|
AGTC Hedge Fund Activity: Q2 2014 in Review
38 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2014, worth a combined $74.3M — up 7,335% from $999K a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new AGTC positions and 1 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jennison Associates, opening a new position worth an estimated $12.5M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $999K sold.
- 38 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2014, up from 1 in Q1 2014.
- Funds reported $74.3M of Applied Genetic Technologies Corporation stock for Q2 2014, up 7,335% quarter-over-quarter.
- 38 funds opened new Applied Genetic Technologies Corporation positions in Q2 2014 and 1 closed out, a net change of +37 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2014 was Jennison Associates, an estimated $12.5M added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2014 was Alyeska Investment Group, an estimated $999K sold.
Based on aggregated 13F filings for Q2 2014.